A 26-week Open Label, Randomised, 2-armed, Parallel Group, Multi-centre Trial Investigating Efficacy and Safety of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn in Combination With the Maximum Tolerated Dose of Metformin and Diet/Exercise on Glycaemic Control in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on the Maximum Tolerated Dose of Metformin ± Other Oral Antidiabetic Drug(s) ± Basal Insulin
Phase of Trial: Phase III
Latest Information Update: 17 Dec 2016
At a glance
- Drugs Insulin detemir (Primary) ; Insulin suspension isophane; Metformin
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Novo Nordisk
- 07 Jun 2017 Biomarkers information updated
- 29 Jul 2016 Status changed from recruiting to completed.
- 02 Jul 2016 The trial was prematurely ended in Croatia (end date: 2016-06-14).